Phototherapy

New phototherapy study findings recently were published by M.J. Saldanha and co-researchers

Published in Drug Law Weekly, May 13th, 2008

"A 46-year-old woman presented with a peripheral vasoproliferative tumor. The tumor was treated with one session of photodynamic therapy with 6 mg/m(2) body surface area of verteporfin and a dose of 100 J/cm(2) delivered in 83 seconds," investigators in the United Kingdom report.

"At the 10-month follow-up examination, involution of the vasoproliferative tumor was seen with improvement of best-corrected visual acuity to 20/80. Photodynamic therapy is an effective treatment option in cases of exudative vasoproliferative tumors," wrote M.J. Saldanha and colleagues.

The researchers concluded: "Great variability exists in the parameters used to treat...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly

Source: Drug Law Weekly (2008-05-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry